Cite
HARVARD Citation
Parker, B. et al. (n.d.). 457: ANTITHROMBIN III (AT3) IN COVID-19: A PILOT STUDY DEFINING AT3 LEVELS AND SAFETY OF EXOGENOUS AT3. Critical care medicine. p. 216. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Parker, B. et al. (n.d.). 457: ANTITHROMBIN III (AT3) IN COVID-19: A PILOT STUDY DEFINING AT3 LEVELS AND SAFETY OF EXOGENOUS AT3. Critical care medicine. p. 216. [Online].